Dermata Therapeutics, Inc. Warrant

YTD

ALL

Why Robinhood?

You can watch DRMAW and buy or sell other stocks, ETFs, and their options commission-free!

About DRMAW

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.

CEO

Gerry Proehl, MBA

CEOGerry Proehl, MBA

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

—

Employees—

DRMAW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

5.23K

Average volume5.23K

High today

$0.0255

High today$0.0255

Low today

$0.0134

Low today$0.0134

Open price

$0.0249

Open price$0.0249

Volume

17.18K

Volume17.18K

52 Week high

$0.044

52 Week high$0.044

52 Week low

$0.007

52 Week low$0.007

Dermata Therapeutics, Inc. Warrant

Why Robinhood?

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. Show more

DRMAW Key Statistics

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.